Brazil continues to lead as the largest medical technology market in Latin America, with the sector’s apparent consumption reaching approximately US$ 15.5 billion (R$ 80 billion) in 2025. The country is followed by Mexico, Colombia, and Argentina in the regional ranking.
The figures come from the “Map of the Medical Technology Sector,” a comprehensive study set to be released on February 26 by Abiis (Brazilian Alliance of Innovative Health Industry). The report compiles economic, production, regulatory, and institutional data from Brazil, Argentina, Canada, Colombia, the United States, and Mexico.
Globally, the medical devices market—which includes everything from low-complexity products to implants, equipment, and software—was valued at US$ 572.3 billion (R$ 2.9 trillion) in 2025. Projections indicate the sector could reach US$ 886.68 billion by 2032, representing a growth of over 54%.
One of the standout segments in Brazil was in vitro diagnostics, which saw a growth rate of 28.4% in 2025.
Brazil also plays a strategic role in regional and global medical technology supply chains, serving as an export platform. Around 22% of Brazil’s medical technology exports are destined for the United States.
Regulatory Challenges
From a regulatory perspective, the study highlights structural limitations that affect efficiency. In particular, there is a noted lack of effective dialogue between Anvisa (the National Health Surveillance Agency) and Inmetro (the National Institute of Metrology, Quality, and Technology).
The comparative analysis of the surveyed countries reveals regulatory complications in most markets. However, only Brazil, Canada, and the United States publish data on medical device approval times. In all three countries, average approval times for higher-risk products have been exceeded.
The “Map of the Medical Technology Sector” provides a detailed look at the opportunities and challenges facing Brazil’s health innovation ecosystem as it seeks to maintain its leadership in Latin America and expand its global footprint.
Source: Folha
